Concept Life Sciences

Executive Summary

Concept Life Sciences is a UK-based Contract Research Organization (CRO) that provides integrated drug discovery and development services, spanning translational biology, end-to-end chemistry, and ADME/DMPK expertise. Founded in 2014 and headquartered in Manchester, the company supports clients from early-stage research through IND-enabling studies across small molecules, biologics, and cell & gene therapies (CGT). By combining multidisciplinary capabilities under one roof, Concept Life Sciences offers a streamlined, cost-effective pathway for biotech and pharmaceutical partners to accelerate their preclinical programs. The CRO's focus on science-driven solutions and its ability to handle complex modalities position it well within the growing outsourced drug development market. Looking ahead, Concept Life Sciences is poised to capitalize on the increasing demand for specialized CRO services, particularly in CGT and biologics. The company's continued investment in capacity and technology, coupled with potential strategic partnerships or funding rounds, could drive significant growth. While operating in a competitive landscape, its differentiated offering and focus on mid-sized biotech clients provide a solid foundation. The near-term outlook hinges on successful execution of service expansions and client acquisition, with a moderate-to-high conviction in its ability to secure new contracts and partnerships.

Upcoming Catalysts (preview)

• Q2 2026Launch of dedicated Cell & Gene Therapy service line80% success
• H1 2026Strategic partnership with a top-20 pharma company for preclinical services60% success
• 2026Series B funding round to expand lab capacity and capabilities70% success